China Ankylosing Spondylitis Drugs Market Research Report 2017

January 2017 | 102 pages | ID: C392F4934B7EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Ankylosing Spondylitis Drugs

Revenue, means the sales value of Ankylosing Spondylitis Drugs

This report studies Ankylosing Spondylitis Drugs in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering

• Abbvie
• Amgen
• Janssen Biotech, Inc.
• Merck & Co.
• UCB
• Boehringer Ingelheim
• Johnson & Johnson

Market Segment by Regions (provinces), covering

• South China
• East China
• Southwest China
• Northeast China
• North China
• Central China
• Northwest China

Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into

• Nonsteroidal anti-inflammatory drugs (NSAIDs)
• TNF blockers and IL-17 inhibitors
• Other

Split by Application, this report focuses on consumption, market share and growth rate of Ankylosing Spondylitis Drugs in each application, can be divided into

• Juveniles
• Adults

Contents

China Ankylosing Spondylitis Drugs Market Research Report 2017

1 ANKYLOSING SPONDYLITIS DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Ankylosing Spondylitis Drugs
1.2 Ankylosing Spondylitis Drugs Segment by Type
  1.2.1 China Production Market Share of Ankylosing Spondylitis Drugs Type in 2015
  1.2.2 Nonsteroidal anti-inflammatory drugs (NSAIDs)
  1.2.3 TNF blockers and IL-17 inhibitors
  1.2.4 Other
1.3 Applications of Ankylosing Spondylitis Drugs
  1.3.1 Ankylosing Spondylitis Drugs Consumption Market Share by Application in 2015
  1.3.2 Juveniles
  1.3.3 Adults
1.4 China Market Size (Value) of Ankylosing Spondylitis Drugs (2011-2021)
1.5 China Ankylosing Spondylitis Drugs Status and Outlook
1.6 Government Policies

2 CHINA ANKYLOSING SPONDYLITIS DRUGS MARKET COMPETITION BY MANUFACTURERS

2.1 China Ankylosing Spondylitis Drugs Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 China Ankylosing Spondylitis Drugs Revenue and Share by Manufacturers (2015 and 2016)
2.3 China Ankylosing Spondylitis Drugs Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Ankylosing Spondylitis Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Ankylosing Spondylitis Drugs Market Competitive Situation and Trends
  2.5.1 Ankylosing Spondylitis Drugs Market Concentration Rate
  2.5.2 Ankylosing Spondylitis Drugs Market Share of Top 3 and Top 5 Manufacturers

3 CHINA ANKYLOSING SPONDYLITIS DRUGS MANUFACTURERS PROFILES/ANALYSIS

3.1 Abbvie
  3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.1.2 Ankylosing Spondylitis Drugs Product Type, Application and Specification
    3.1.2.1 Nonsteroidal anti-inflammatory drugs (NSAIDs)
    3.1.2.2 TNF blockers and IL-17 inhibitors
  3.1.3 Abbvie Ankylosing Spondylitis Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.1.4 Main Business/Business Overview
3.2 Amgen
  3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.2.2 Ankylosing Spondylitis Drugs Product Type, Application and Specification
    3.2.2.1 Nonsteroidal anti-inflammatory drugs (NSAIDs)
    3.2.2.2 TNF blockers and IL-17 inhibitors
  3.2.3 Amgen 102 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.2.4 Main Business/Business Overview
3.3 Janssen Biotech, Inc.
  3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.3.2 Ankylosing Spondylitis Drugs Product Type, Application and Specification
    3.3.2.1 Nonsteroidal anti-inflammatory drugs (NSAIDs)
    3.3.2.2 TNF blockers and IL-17 inhibitors
  3.3.3 Janssen Biotech, Inc. 110 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.3.4 Main Business/Business Overview
3.4 Merck & Co.
  3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.4.2 Ankylosing Spondylitis Drugs Product Type, Application and Specification
    3.4.2.1 Nonsteroidal anti-inflammatory drugs (NSAIDs)
    3.4.2.2 TNF blockers and IL-17 inhibitors
  3.4.3 Merck & Co. Jan Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.4.4 Main Business/Business Overview
3.5 UCB
  3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.5.2 Ankylosing Spondylitis Drugs Product Type, Application and Specification
    3.5.2.1 Nonsteroidal anti-inflammatory drugs (NSAIDs)
    3.5.2.2 TNF blockers and IL-17 inhibitors
  3.5.3 UCB Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.5.4 Main Business/Business Overview
3.6 Boehringer Ingelheim
  3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.6.2 Ankylosing Spondylitis Drugs Product Type, Application and Specification
    3.6.2.1 Nonsteroidal anti-inflammatory drugs (NSAIDs)
    3.6.2.2 TNF blockers and IL-17 inhibitors
  3.6.3 Boehringer Ingelheim Million USD Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.6.4 Main Business/Business Overview
3.7 Johnson & Johnson
  3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.7.2 Ankylosing Spondylitis Drugs Product Type, Application and Specification
    3.7.2.1 Nonsteroidal anti-inflammatory drugs (NSAIDs)
    3.7.2.2 TNF blockers and IL-17 inhibitors
  3.7.3 Johnson & Johnson Pharma & Healthcare Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.7.4 Main Business/Business Overview

4 CHINA ANKYLOSING SPONDYLITIS DRUGS CAPACITY, PRODUCTION, REVENUE, CONSUMPTION, EXPORT AND IMPORT (2011-2016)

4.1 China Ankylosing Spondylitis Drugs Capacity, Production and Growth (2011-2016)
4.2 China Ankylosing Spondylitis Drugs Revenue and Growth (2011-2016)
4.3 China Ankylosing Spondylitis Drugs Production, Consumption, Export and Import (2011-2016)

5 CHINA ANKYLOSING SPONDYLITIS DRUGS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 China Ankylosing Spondylitis Drugs Production and Market Share by Type (2011-2016)
5.2 China Ankylosing Spondylitis Drugs Revenue and Market Share by Type (2011-2016)
5.3 China Ankylosing Spondylitis Drugs Price by Type (2011-2016)
5.4 China Ankylosing Spondylitis Drugs Production Growth by Type (2011-2016)

6 CHINA ANKYLOSING SPONDYLITIS DRUGS MARKET ANALYSIS BY APPLICATION

6.1 China Ankylosing Spondylitis Drugs Consumption and Market Share by Application (2011-2016)
6.2 China Ankylosing Spondylitis Drugs Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Application
  6.3.2 Emerging Markets/Countries

7 CHINAANKYLOSING SPONDYLITIS DRUGS MARKET ANALYSIS BY REGIONS (PROVINCES)

7.1 China Ankylosing Spondylitis Drugs Production, Production Value and Price by Regions (Provinces)(2011-2016)
  7.1.1 China Ankylosing Spondylitis Drugs Production and Market Share by Regions (Provinces)(2011-2016)
  7.1.2 China Ankylosing Spondylitis Drugs Production Value and Market Share by Regions (Provinces)(2011-2016)
  7.1.3 China Ankylosing Spondylitis Drugs Sales Price by Regions (Provinces)(2011-2016)
7.2 China Ankylosing Spondylitis Drugs Consumption by Regions (Provinces)(2011-2016)
7.3 China Ankylosing Spondylitis Drugs Production, Consumption, Export and Import (2011-2016)

8 ANKYLOSING SPONDYLITIS DRUGS MANUFACTURING COST ANALYSIS

8.1 Ankylosing Spondylitis Drugs Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Ankylosing Spondylitis Drugs

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Ankylosing Spondylitis Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Ankylosing Spondylitis Drugs Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 CHINA ANKYLOSING SPONDYLITIS DRUGS MARKET FORECAST (2016-2021)

12.1 China Ankylosing Spondylitis Drugs Capacity, Production, Revenue Forecast (2016-2021)
12.2 China Ankylosing Spondylitis Drugs Production, Import, Export and Consumption Forecast (2016-2021)
12.3 China Ankylosing Spondylitis Drugs Production Forecast by Type (2016-2021)
12.4 China Ankylosing Spondylitis Drugs Consumption Forecast by Application (2016-2021)
12.5 China Ankylosing Spondylitis Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2016-2021)
  12.5.1 China Ankylosing Spondylitis Drugs Production Forecast by Regions (Provinces)(2016-2021)
  12.5.2 China Ankylosing Spondylitis Drugs Consumption Forecast by Regions (Provinces)(2016-2021)
  12.5.3 China Ankylosing Spondylitis Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2016-2021)
12.6 Ankylosing Spondylitis Drugs Price Forecast (2016-2021)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Ankylosing Spondylitis Drugs
Figure China Production Market Share of Ankylosing Spondylitis Drugs by Type in 2015
Figure Product Picture of Nonsteroidal anti-inflammatory drugs (NSAIDs)
Table Major Manufacturers of Nonsteroidal anti-inflammatory drugs (NSAIDs)
Figure Product Picture of TNF blockers and IL-17 inhibitors
Table Major Manufacturers of TNF blockers and IL-17 inhibitors
Figure Product Picture of Other
Table Major Manufacturers of Other
Table Ankylosing Spondylitis Drugs Consumption Market Share by Application in 2015
Figure Juveniles Examples
Figure Adults Examples
Figure China Ankylosing Spondylitis Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Table China Ankylosing Spondylitis Drugs Capacity of Key Manufacturers (2015 and 2016)
Table China Ankylosing Spondylitis Drugs Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Ankylosing Spondylitis Drugs Capacity of Key Manufacturers in 2015
Figure China Ankylosing Spondylitis Drugs Capacity of Key Manufacturers in 2016
Table China Ankylosing Spondylitis Drugs Production of Key Manufacturers (2015 and 2016)
Table China Ankylosing Spondylitis Drugs Production Share by Manufacturers (2015 and 2016)
Figure 2015 Ankylosing Spondylitis Drugs Production Share by Manufacturers
Figure 2016 Ankylosing Spondylitis Drugs Production Share by Manufacturers
Table China Ankylosing Spondylitis Drugs Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Ankylosing Spondylitis Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Ankylosing Spondylitis Drugs Revenue Share by Manufacturers
Table 2016 China Ankylosing Spondylitis Drugs Revenue Share by Manufacturers
Table China Market Ankylosing Spondylitis Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Ankylosing Spondylitis Drugs Average Price of Key Manufacturers in 2015
Table Manufacturers Ankylosing Spondylitis Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Ankylosing Spondylitis Drugs Product Type
Figure Ankylosing Spondylitis Drugs Market Share of Top 3 Manufacturers
Figure Ankylosing Spondylitis Drugs Market Share of Top 5 Manufacturers
Table Abbvie Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Abbvie Ankylosing Spondylitis Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Abbvie Ankylosing Spondylitis Drugs Market Share (2011-2016)
Table Amgen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Amgen Ankylosing Spondylitis Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Amgen Ankylosing Spondylitis Drugs Market Share (2011-2016)
Table Janssen Biotech, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Janssen Biotech, Inc. Ankylosing Spondylitis Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Janssen Biotech, Inc. Ankylosing Spondylitis Drugs Market Share (2011-2016)
Table Merck & Co. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck & Co. Ankylosing Spondylitis Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Merck & Co. Ankylosing Spondylitis Drugs Market Share (2011-2016)
Table UCB Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table UCB Ankylosing Spondylitis Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure UCB Ankylosing Spondylitis Drugs Market Share (2011-2016)
Table Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Boehringer Ingelheim Ankylosing Spondylitis Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Boehringer Ingelheim Ankylosing Spondylitis Drugs Market Share (2011-2016)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Ankylosing Spondylitis Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Johnson & Johnson Ankylosing Spondylitis Drugs Market Share (2011-2016)
Figure China Ankylosing Spondylitis Drugs Capacity, Production and Growth (2011-2016)
Figure China Ankylosing Spondylitis Drugs Revenue (Million USD) and Growth (2011-2016)
Table China Ankylosing Spondylitis Drugs Production, Consumption, Export and Import (2011-2016)
Table China Ankylosing Spondylitis Drugs Production by Type (2011-2016)
Table China Ankylosing Spondylitis Drugs Production Share by Type (2011-2016)
Figure Production Market Share of Ankylosing Spondylitis Drugs by Type (2011-2016)
Figure 2015 Production Market Share of Ankylosing Spondylitis Drugs by Type
Table China Ankylosing Spondylitis Drugs Revenue by Type (2011-2016)
Table China Ankylosing Spondylitis Drugs Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Ankylosing Spondylitis Drugs by Type (2011-2016)
Figure 2015 Revenue Market Share of Ankylosing Spondylitis Drugs by Type
Table China Ankylosing Spondylitis Drugs Price by Type (2011-2016)
Figure China Ankylosing Spondylitis Drugs Production Growth by Type (2011-2016)
Table China Ankylosing Spondylitis Drugs Consumption by Application (2011-2016)
Table China Ankylosing Spondylitis Drugs Consumption Market Share by Application (2011-2016)
Figure China Ankylosing Spondylitis Drugs Consumption Market Share by Application in 2015
Table China Ankylosing Spondylitis Drugs Consumption Growth Rate by Application (2011-2016)
Figure China Ankylosing Spondylitis Drugs Consumption Growth Rate by Application (2011-2016)
Table China Ankylosing Spondylitis Drugs Production by Regions (Provinces)(2011-2016)
Table China Ankylosing Spondylitis Drugs Production Market Share by Regions (Provinces)(2011-2016)
Table China Ankylosing Spondylitis Drugs Production Value by Regions (Provinces)(2011-2016)
Table China Ankylosing Spondylitis Drugs Production Value Market Share by Regions (Provinces)(2011-2016)
Table China Ankylosing Spondylitis Drugs Sales Price by Regions (Provinces)(2011-2016)
Table China Ankylosing Spondylitis Drugs Consumption by Regions (Provinces)(2011-2016)
Table China Ankylosing Spondylitis Drugs Consumption Market Share by Regions (Provinces)(2011-2016)
Table China Ankylosing Spondylitis Drugs Production, Consumption, Export and Import (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Ankylosing Spondylitis Drugs
Figure Manufacturing Process Analysis of Ankylosing Spondylitis Drugs
Figure Ankylosing Spondylitis Drugs Industrial Chain Analysis
Table Raw Materials Sources of Ankylosing Spondylitis Drugs Major Manufacturers in 2015
Table Major Buyers of Ankylosing Spondylitis Drugs
Table Distributors/Traders List
Figure China Ankylosing Spondylitis Drugs Capacity, Production and Growth Rate Forecast (2016-2021)
Figure China Ankylosing Spondylitis Drugs Revenue and Growth Rate Forecast (2016-2021)
Table China Ankylosing Spondylitis Drugs Production, Import, Export and Consumption Forecast (2016-2021)
Table China Ankylosing Spondylitis Drugs Production Forecast by Type (2016-2021)
Table China Ankylosing Spondylitis Drugs Consumption Forecast by Application (2016-2021)
Table China Ankylosing Spondylitis Drugs Production Forecast by Regions (Provinces)(2016-2021)
Table China Ankylosing Spondylitis Drugs Consumption Forecast by Regions (Provinces)(2016-2021)
Table China Ankylosing Spondylitis Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2016-2021)